Researchers have developed a faster and cheaper way to analyze genetic information from prenatal blood tests without sacrificing accuracy. By removing unnecessary computer processing steps, scientists cut computing time dramatically while maintaining over 96% accuracy for identifying folate metabolism genes in 517 real prenatal samples, according to Gram Research analysis. This simplified approach could make genetic screening more accessible and affordable for pregnant people.
Scientists have figured out a faster way to analyze genetic information from prenatal blood tests without losing accuracy. Normally, this process involves many time-consuming computer steps that don’t actually help with low-depth genetic data. Researchers tested a simpler approach and found it works just as well while saving significant computing time and money. They also developed a better method for combining results from large groups of samples. When they tested this new system on real prenatal samples, it accurately identified genes related to how mothers process folate, a B vitamin important for pregnancy. This discovery could make genetic screening faster and more affordable for pregnant people.
Key Statistics
A 2026 research study of 517 prenatal samples found that removing standard computer processing steps maintained over 96% accuracy for identifying folate metabolism genes while substantially reducing computational time.
Researchers validated a batch-merging method that combined imputation results from multiple sample groups with nearly identical accuracy to processing all samples together, enabling large-scale genetic screening.
The simplified prenatal genetic testing workflow achieved 96% or higher concordance for both genotype and allele identification at the MTHFR rs1801131 and MTRR rs1801394 loci compared to gold-standard sequencing methods.
The Quick Take
- What they studied: Whether removing certain computer processing steps from prenatal genetic testing would still give accurate results, and how to combine results from multiple batches of samples.
- Who participated: 517 real prenatal blood samples from pregnant people, compared against a more detailed sequencing method to check accuracy.
- Key finding: Skipping standard computer processing steps cut computing time dramatically while maintaining over 96% accuracy for identifying folate metabolism genes, according to Gram Research analysis of this 2026 study.
- What it means for you: Prenatal genetic screening could become faster and cheaper without sacrificing accuracy, potentially making it more accessible to more pregnant people. However, this applies specifically to screening for folate metabolism genes and may not apply to all genetic tests.
The Research Details
Researchers took genetic data from prenatal blood tests, which produce massive amounts of information but at lower quality than traditional genetic testing. They compared two approaches: the standard method that includes multiple computer processing steps (like marking duplicate readings and adjusting quality scores), and a simplified method that skips these steps. They tested both approaches on simulated data at different quality levels to see if accuracy suffered. They also developed a new mathematical method for combining results when samples are processed in separate batches, rather than all together. Finally, they applied their simplified pipeline to 517 real prenatal samples and checked the results against a gold-standard sequencing method to confirm accuracy.
Prenatal blood tests generate enormous datasets that are expensive and time-consuming to process. If researchers can skip unnecessary steps without losing accuracy, they can screen more samples faster and at lower cost. This matters because it could make genetic screening more widely available and affordable for pregnant people who want to understand their genetic traits that might affect pregnancy.
The study used real-world samples and compared results to a proven gold-standard method, which strengthens confidence in the findings. The researchers tested their approach at multiple simulated data quality levels before applying it to real samples. The accuracy rates exceeded 96%, which is considered very high in genetic testing. However, the study focused specifically on folate metabolism genes, so results may not apply equally to all genetic variants.
What the Results Show
Removing standard computer processing steps did not reduce accuracy. When researchers tested the simplified approach on simulated data at various quality levels, it performed just as well as the traditional method. This is significant because these processing steps were originally designed for high-quality genetic data, not the lower-quality data from prenatal blood tests. The simplified approach cut computing time substantially, meaning results could be generated much faster. The researchers also developed a new method for combining results from multiple batches of samples using weighted averaging. This method produced results nearly identical to processing all samples together at once, solving a major practical problem when screening large populations.
When applied to real prenatal samples, the pipeline accurately identified two specific genes related to folate metabolism: MTHFR and MTRR. Both genes showed over 96% accuracy when compared to the gold-standard sequencing method. This high accuracy suggests the simplified approach works reliably in real-world clinical settings, not just in computer simulations. The cost-effectiveness of the approach was notable, as it uses existing clinical sequencing data without requiring additional laboratory work.
Previous research assumed that standard computer processing steps were necessary for all genetic data analysis. This study challenges that assumption for low-depth prenatal data specifically. The batch-merging method addresses a gap in existing literature, as most previous studies either processed all samples together or didn’t address how to accurately combine results from separate batches. The findings align with a growing trend in genetic research toward streamlining workflows for specific data types rather than applying one-size-fits-all approaches.
The study focused specifically on folate metabolism genes, so results may not apply equally to screening for other genetic variants. The sample size of 517 is moderate for genetic studies and may not capture rare genetic variations. The research was conducted in a research setting and would need validation in actual clinical prenatal screening programs. The study doesn’t address whether the simplified approach works equally well for all ethnic backgrounds, as genetic variation differs across populations.
The Bottom Line
Healthcare providers and genetic testing laboratories can consider adopting this simplified workflow for prenatal screening focused on folate metabolism genes. The evidence is strong (based on real-world validation with 96%+ accuracy) that this approach maintains accuracy while reducing costs and processing time. However, this recommendation applies specifically to folate metabolism screening and should not be automatically extended to all prenatal genetic tests without additional validation.
Pregnant people considering prenatal genetic screening for folate metabolism variants should know this technology may become more accessible and affordable. Genetic testing laboratories and healthcare systems should care because this approach could reduce costs and processing time. Researchers studying maternal genetics should care because it provides a validated, efficient method for large-scale screening. People without specific interest in folate metabolism genetics may not need to apply these findings directly.
If laboratories adopt this workflow, faster results could be available within months to a year. Cost reductions would likely follow as the approach becomes standard practice. However, widespread clinical implementation typically takes 1 to 3 years as healthcare systems validate and integrate new methods.
Frequently Asked Questions
Can prenatal blood tests check for folate metabolism genes?
Yes, prenatal blood tests can now identify folate metabolism genes like MTHFR and MTRR using a new simplified analysis method. A 2026 study of 517 samples achieved over 96% accuracy compared to standard sequencing, making this screening faster and more cost-effective.
Does skipping computer processing steps make prenatal genetic tests less accurate?
No, research shows that removing unnecessary computer processing steps from prenatal genetic analysis maintains accuracy while cutting processing time significantly. This works because these steps were designed for different types of genetic data than prenatal blood tests produce.
How long does it take to get results from prenatal genetic screening?
With the new simplified workflow, results could be available faster than traditional methods, potentially within days rather than weeks. However, actual turnaround time depends on individual laboratory practices and how quickly they adopt this technology.
Will this new method make prenatal genetic testing cheaper?
The simplified workflow should reduce costs by cutting computing time and resources needed for analysis. As laboratories adopt this method, prenatal genetic screening for folate metabolism genes could become more affordable and accessible.
What should I do if my prenatal test shows a folate metabolism gene variant?
Discuss results with your healthcare provider, who may recommend methylfolate supplementation instead of standard folic acid. Ensure adequate folate intake through diet and supplements, as this supports healthy pregnancy outcomes for people with certain genetic variants.
Want to Apply This Research?
- Track folate intake and supplementation daily (target 400 to 800 micrograms for pregnant people) alongside any genetic test results for folate metabolism genes. Note any symptoms like fatigue or mood changes that might relate to folate status.
- If genetic testing shows variants in folate metabolism genes, users could set reminders to take prenatal vitamins with methylfolate (an active form of folate) rather than standard folic acid, based on healthcare provider recommendations. Log daily supplement intake and any dietary sources of folate.
- Create a long-term log tracking folate supplementation, dietary folate sources, energy levels, and any pregnancy-related symptoms. Review monthly to identify patterns and share with healthcare providers at prenatal appointments. This helps personalize folate management based on individual genetic variants.
This research describes a technical improvement in how prenatal genetic data is analyzed and does not constitute medical advice. Prenatal genetic testing decisions should be made in consultation with qualified healthcare providers, genetic counselors, or maternal-fetal medicine specialists. Results from genetic tests should be interpreted by qualified professionals who understand your individual health situation, family history, and pregnancy circumstances. If you have questions about folate metabolism, prenatal screening, or supplementation during pregnancy, consult your obstetrician or healthcare provider before making any changes to your care plan.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.